Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS    
Sublicense revenue $ 354,100 $ 0
Total revenues 354,100 0
Operating expenses:    
Research and development 5,603,600 1,731,200
General and administrative 2,496,700 1,390,600
Total operating expenses 8,100,300 3,121,800
Loss from operations (7,746,200) (3,121,800)
Other income (expenses), net:    
Interest income (expense), net 5,100 (3,200)
Other income 0 600
Loss before income taxes (7,741,100) (3,124,400)
Income taxes (3,400) (2,400)
Net loss and comprehensive loss (7,744,500) (3,126,800)
Accrued dividends on Series B Preferred stock (361,800) (335,800)
Net loss attributable to common stockholders $ (8,106,300) $ (3,462,600)
Basic and diluted net loss attributable to common stockholders per common share $ (0.04) $ (0.07)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 189,924,158 51,321,355